Rhenman & Partners Asset Management Ab Shockwave Medical, Inc. Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $14.5 Million - $24.7 Million	-76,000 Reduced 54.29%	64,000 $20.8 Million
Q4 2023 Feb 13, 2024	BUY	$160.99 - $215.69 $9.5 Million - $12.7 Million	59,000 Added 72.84%	140,000 $26.7 Million
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $13.4 Million - $19.6 Million	-69,000 Reduced 46.0%	81,000 $16.1 Million
Q3 2023 Nov 09, 2023	BUY	$194.33 - $283.97 $18.3 Million - $26.7 Million	94,000 Added 167.86%	150,000 $29.9 Million
Q2 2023 Aug 11, 2023	SELL	$223.05 - $302.68 $2.45 Million - $3.33 Million	-11,000 Reduced 16.42%	56,000 $16 Million
Q1 2023 May 11, 2023	BUY	$175.41 - $217.92 $3.51 Million - $4.36 Million	20,000 Added 42.55%	67,000 $14.5 Million
Q4 2022 Feb 13, 2023	BUY	$204.38 - $296.82 $5.52 Million - $8.01 Million	27,000 Added 135.0%	47,000 $9.66 Million
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $9.95 Million - $15.8 Million	-50,978 Reduced 71.82%	20,000 $5.86 Million
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $1.88 Million - $3.47 Million	16,178 Added 29.52%	70,978 $13.6 Million
Q1 2022 May 13, 2022	BUY	$127.96 - $207.36 $2.66 Million - $4.31 Million	20,800 Added 61.18%	54,800 $11.4 Million
Q3 2021 Nov 12, 2021	BUY	$163.99 - $235.57 $1,639 - $2,355	10 Added 0.03%	34,000 $7 Million
Q2 2021 Aug 13, 2021	SELL	$131.45 - $201.49 $2.1 Million - $3.23 Million	-16,010 Reduced 32.02%	33,990 $6.45 Million
Q1 2021 May 14, 2021	SELL	$92.73 - $142.05 $927,300 - $1.42 Million	-10,000 Reduced 16.67%	50,000 $6.51 Million
Q2 2020 Jul 16, 2020	BUY	$27.25 - $47.53 $1.64 Million - $2.85 Million	60,000 New	60,000 $2.84 Million

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account